Global CD25 (IL2R alpha) ELISA Kit Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global CD25 (IL2R alpha) ELISA Kit market size was valued at US$ 12 million in 2024 and is forecast to a readjusted size of USD 18.9 million by 2031 with a CAGR of 6.7% during review period.

CD25(IL2Ra) ELISA Kit is an experimental tool used to measure the concentration of CD25 protein in a sample.

CD25 is the α chain of IL-2 receptor, which is a part of the immunoglobulin superfamily. It plays an important role in the immune system and is mainly involved in the regulation of T cell activation and immune response. By using the CD25 ELISA kit, specific antibodies can be used to capture the CD25 protein in the sample, and then its concentration can be accurately determined by measuring the color change. The application of this kit will help in-depth study of the function and regulatory mechanism of CD25 in immune regulation, T cell activation and immune-related disease mechanisms, and provide an important tool for immunology research and clinical diagnosis.

This report is a detailed and comprehensive analysis for global CD25 (IL2R alpha) ELISA Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global CD25 (IL2R alpha) ELISA Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CD25 (IL2R alpha) ELISA Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CD25 (IL2R alpha) ELISA Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global CD25 (IL2R alpha) ELISA Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for CD25 (IL2R alpha) ELISA Kit

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global CD25 (IL2R alpha) ELISA Kit market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bio-Techne, Thermo Fisher Scientific (China) Co., Ltd., Cell Sciences, Inc., Assay Genie, MyBiosource, Inc., Boster Biological Technology, Wuhan Fine Biotech Co., Ltd., Abcam, Arigo Biolaboratories Corp., LifeSpan BioSciences, Inc, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

CD25 (IL2R alpha) ELISA Kit market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Human

Mouse

Rat

Others

Market segment by Application

Hospital

Research Institute

Others

Major players covered

Bio-Techne

Thermo Fisher Scientific (China) Co., Ltd.

Cell Sciences, Inc.

Assay Genie

MyBiosource, Inc.

Boster Biological Technology

Wuhan Fine Biotech Co., Ltd.

Abcam

Arigo Biolaboratories Corp.

LifeSpan BioSciences, Inc

CUSABIO

Geno Technology, Inc.

CLOUD-CLONE CORP.

RayBiotech, Inc.

Biorbyt

Biomatik

ZodelBiotec Ltd.

Innovative Research

Abbexa

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe CD25 (IL2R alpha) ELISA Kit product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of CD25 (IL2R alpha) ELISA Kit, with price, sales quantity, revenue, and global market share of CD25 (IL2R alpha) ELISA Kit from 2020 to 2025.

Chapter 3, the CD25 (IL2R alpha) ELISA Kit competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the CD25 (IL2R alpha) ELISA Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and CD25 (IL2R alpha) ELISA Kit market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of CD25 (IL2R alpha) ELISA Kit.

Chapter 14 and 15, to describe CD25 (IL2R alpha) ELISA Kit sales channel, distributors, customers, research findings and conclusion.